AbbVie Japan Office - Tokyo, Japan
3-1-21, Shibaura, Minato-ku, Tokyo, 108-0023

If you would like to browse the AbbVie Japanese site for more information, please click here.


At AbbVie, we partner to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people's lives.

AbbVie is seeking to explore exciting new cross-border licensing opportunities with innovative biotechs in Asia.  In addition to attending the General Session presentations and networking activities, academic technology transfer offices, VCs and biotechs are welcome to apply for 1:1 meetings with AbbVie senior executives.  1:1 meetings will take place after the General Session.

AbbVie Partnering Day provides an opportunity to:

  • Meet with our senior research and partnership leadership teams from AbbVie External Innovations and R&D to discuss your ideas and research in a 1:1 setting

  • Learn about our strategy, therapeutic areas of interest, approach(es) to partnering, and capabilities

  • Share information about your company, pipeline, and discovery platforms with members of the AbbVie R&D and AbbVie External Innovations teams

Complete Form to Register

The personal information you enter will be used only for the purpose of your inquiry.  Please refer to our Privacy Policy regarding the handling of personal information.

Click Here to View AbbVie Japan Privacy Policy
Click Here to View AbbVie Global Privacy Policy


For more information on AbbVie's therapeutic interests, click here.

You may register to attend only the General Session presentations.  There is no fee to register.  

Due to limited space, only up to 2 representatives from the same company may register.  Vendors/service providers are not eligible to join.

For 1:1 meetings, you must first apply by sending non-confidential supporting documents in English.  You will be notified via email if your 1:1 meeting is confirmed.

Please email [email protected] to apply for 1:1 meetings.  For more information, please refer to Guidelines below.

Guidelines for 1:1 Meeting Application & Pitch Deck Seminar

If you are interested in applying for a 1:1 meeting with senior AbbVie executives, please follow the guidelines below:

1. All applications for 1:1 meetings and/or for those planning to attend the Pitch Deck Seminar must include non-confidential supporting materials in English, such as slide decks, poster presentations, and/or research papers.

2. The deadline to apply is by March 28, 2025.  To apply, please send an email with your supporting documents to [email protected].

3.  Project proposals will be evaluated based on project stage, strategic fit, and differentiation.

4. You will receive notification via email if your 1:1 meeting is approved/confirmed.

5. For more information on AbbVie's partnering approach, please visit AbbVie Partnering Site.

POLICY FOR ELECTRONIC SUBMISSIONS

AbbVie accepts license candidates or research programs under the following terms and conditions.

1. You represent that the information you provide in this web site is original to you and that you are under no contractual or legal obligation to maintain such information in confidence.

2. You acknowledge that you are 18 years of age or older, and can form a legally binding contract under applicable law.

3. You acknowledge that AbbVie is not receiving your information or suggestion in confidence, and that receipt of your information or suggestion does not create a confidential relationship between AbbVie and you.

4. All your rights and remedies arising out of your disclosure to AbbVie are limited exclusively to rights and remedies under United States patent law and copyright law.

Almost done. Where should we send the confirmation?

RegFox Event Registration Software
Event Registration Software by RegFox